Karen Santiago - Bristol Myer Senior Vice President Controller

<div class='logoBackup' style='background:#0D52D1;color: white;font-size:3em;;'>BMY</div>
BMYMP -- USA Stock  

USD 1,125  124.43  12.43%

Ms. Karen Murphy Santiago is appointed as Senior Vice President, Corporationrationrate Controller of the company effective February 15, 2018. She joined BristolMyers Squibb Company in 2003 and has served in multiple roles of increasing responsibility. Most recently, from 2012 to 2015 she served as Vice President, Finance for Global Manufacturing and Supply, from 2015 to 2016 as Vice President, Finance for US and Puerto Rico Commercial and since 2016 she was Vice President, Lead for Enabling Functions and Finance Transformation
Age: 47  President Since 2018  MBA    
212-546-4000  http://www.bms.com
Santiago has an M.B.A. in Finance and a B.S. in Accounting and is a Certified Public Accountant.

Management Efficiency

The company has return on total asset (ROA) of 10.68 % which means that it generated profit of $10.68 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 2.97 % meaning that it generated $2.97 on every $100 dollars invested by stockholders.
The company has accumulated 7.39 B in total debt with debt to equity ratio (D/E) of 59.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bristol Myer Squi has Current Ratio of 1.37 which is within standard range for the sector.

Similar Executives

Showing few of many executives


C GiraudConcho Resources
Brendy SealockConAgra Brands
Darren SerraoConAgra Brands
Charisse BrockConAgra Brands
Mark SnyderCONMED Corporation
Barry CalpinoConAgra Brands
Keith CorbettConcho Resources
Travis CountsConcho Resources
Jonathan HarrisConAgra Brands
Thomas WernerConAgra Brands
Scott TurcoGoldman Sachs BDC
Scott KidwellConcho Resources
Erick NelsonConcho Resources
Johan NystedtConAgra Brands
Megan HaysConcho Resources
Mary BerryConcho Resources
Nathan FolkertCONMED Corporation
Price MoncriefConcho Resources
Clay BatemanConcho Resources
Robert EnslinSAP SE ADS
Stanley PetersCONMED Corporation

Entity Summary

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.Bristol Myer Squi Pf [BMYMP] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Bristol Myer Squi Leadership Team

Ann Powell, Chief Human Resource Officer, Senior Vice President
Togo West, Independent Director
Karen Vousden, Director
Adam Dubow, Senior Vice President Chief Compliance Officer and Ethics Officer
Alan Lacy, Independent Director
Robert Bertolini, Independent Director
Jose Baselga, Independent Director
Charles Bancroft, CFO, Executive Vice President
Gerald Storch, Independent Director
Louis Schmukler, President - Global Manufacturing and Supply
Michael Grobstein, Independent Director
Christopher Boerner, Executive Vice President and Chief Commercial Officer
John Elicker, Senior Vice President - Public Affairs and Investor Relations
Anne Nielsen, Senior Vice President Chief Compliance and Ethics Officer
Karen Santiago, Senior Vice President Controller
Giovanni Caforio, COO, Director
Vicki Sato, Independent Director
Emmanuel Blin, Senior Vice President Chief Strategy Officer
Joseph Caldarella, Senior Vice President Corporate Controller
Laurie Glimcher, Independent Director
Murdo Gordon, Executive Vice President Chief Commercial Officer
Lamberto Andreotti, CEO, Director
Thomas Lynch, Independent Director
Dinesh Paliwal, Independent Director
Lewis Campbell, Independent Director
Theodore Samuels, Independent Director
Samuel Moed, Senior Vice President - Strategic Planning and Analysis
Matthew Emmens, Independent Director
Ann Judge, Senior Vice President - Global Human Resources
Sandra Leung, General Counsel, Corporate Secretary
Paul Autenried, Senior Vice President - Enterprise Services, CIO
Francis Cuss, Executive Vice President Chief Scientific Officer
Paul Biondi, Senior Vice President Head - Business Development
Peter Arduini, Independent Director

Stock Performance Indicators

Current Sentiment - BMYMP

Bristol Myer Squi Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in Bristol Myer Squi Pf. What is your opinion about investing in Bristol Myer Squi Pf? Are you bullish or bearish?
50% Bullish
50% Bearish

Bristol Myer Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bristol Myer and Goldman Sachs BDC. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.